Tryton Medical raises $20 million it plans to use to fund a clinical trial ahead of its bid for FDA approval of its side-branch coronary stent.
Tryton Medical said today that's made an initial closing on a $20 million private equity round from existing and new investors.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1tmUBQf
Cap comentari:
Publica un comentari a l'entrada